Apo-Mycophenolic Acid 180 mg

APO-Myphenolic Acid 180 MG is an enteric-coated tablet containing mycophenolic acid, used to prevent organ rejection post-transplant. This immunosuppressant is commonly prescribed for kidney, heart, or liver transplant patients.

APO-Myphenolic Acid 180 MG is primarily used to prevent rejection in patients who have received an organ transplant. It works by suppressing the immune system to help the body accept the new organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness. Patients should consult their healthcare provider to understand what APO-Myphenolic Acid is used for in their specific case.

Common effects of APO-Myphenolic Acid 180 MG may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue, fever, or infections due to the immunosuppressant nature of the drug. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

APO-Myphenolic Acid 180 MG should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause birth defects. Patients should avoid activities that require alertness until they know how the medication affects them. Regular blood tests may be necessary to monitor blood cell counts and liver function.

APO-Myphenolic Acid 180 MG may interact with other medications, including antacids, cholestyramine, and certain antibiotics. Alcohol should be avoided as it can increase the risk of side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.